TITLE

Associated liver enzymes with hyperlipidemic profile in type 2 diabetes patients

AUTHOR(S)
Al-Jameil, Noura; Khan, Farah A.; Arjumand, Sadia; Khan, Mohammad F.; Tabassum, Hajera
PUB. DATE
July 2014
SOURCE
International Journal of Clinical & Experimental Pathology;2014, Vol. 7 Issue 7, p4345
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
97436108

 

Related Articles

  • Association of Diabetic Nephropathy and Liver Disorders. ADIGA, USHA SACHIDANANDA; MALAWADI, B. N. // Journal of Clinical & Diagnostic Research;Oct2016, Vol. 10 Issue 10, p5 

    Introduction: Liver disorder is known to be a risk factor for Diabetes Mellitus (DM) and diabetic patients are at risk of developing liver disorders. Association of liver and renal disease is less explored in the field of research; hence, we conducted a retrospective study on this. Aim: To...

  • Prevalence of nonalcoholic fatty liver disease and its biochemical predictors in patients with type-2 diabetic mellitus. Krishnan, Arunkumar; Venkataraman, Jayanthi // Experimental & Clinical Hepatology;2011, Vol. 7 Issue 3/4, p7 

    Background: Nonalcoholic fatty liver disease (NAFLD) is emerging as the most common chronic liver condition in the Western world and it is commonly associated with type 2 diabetes mellitus (DM). The aim of this study to determine the prevalence of NAFLD, and identify the predisposing factors in...

  • Hepatomegaly in Type 1 Diabetes Mellitus: When to Suspect of Glycogenic Hepatopathy? Jardim, Joana; Trindade, Eunice; Carneiro, Fatima; Dias, Jorge Amil // Journal of Medical Cases;2013, Vol. 4 Issue 11, p726 

    Uncontrolled type 1 diabetes mellitus is associated with recognized short- and long-term complications. The authors describe a case of a female adolescent, with history of poorly controlled type 1 diabetes mellitus, who presented with tender hepatomegaly and elevated liver enzymes. Her growth...

  • Poorly controlled type 1 diabetes mellitus associated with liver glycogen deposition and abnormal liver enzymes. Hoffman, Seth D; Yong, Sherri; Li, Shilun D // American Journal of Gastroenterology (Springer Nature);Sep2003 Supplement, Vol. 98, pS204 

    An abstract of the article "Poorly Controlled Type 1 Diabetes Mellitus Associated with Liver Glycogen Deposition and Abnormal Liver Enzymes" by Seth D. Hoffman, Sherri Yong, and Shilun D. Li is presented.

  • Association of HELLP syndrome with autoimmune antibodies and glucose intolerance. Weitgasser, Raimund; Spitzer, Dietmar; Kartnig, Ilse; Zajc, Michael; Staudach, Alfons; Sandhofer, Friedrich; Weitgasser, R; Spitzer, D; Kartnig, I; Zajc, M; Staudach, A; Sandhofer, F // Diabetes Care;Jun2000, Vol. 23 Issue 6, p786 

    Objective: HELLP syndrome is a severe form of preeclampsia, characterized by hemolysis (H), elevated liver enzymes (EL), and low platelets (LP), whose pathogenesis is unclear. Autoimmunity is thought to play an important role. After the observation of development of type 1 diabetes...

  • Gene Expression Profile Analysis of Type 2 Diabetic Mouse Liver. Zhang, Fang; Xu, Xiang; Zhang, Yi; Zhou, Ben; He, Zhishui; Zhai, Qiwei // PLoS ONE;Mar2013, Vol. 8 Issue 3, p1 

    Liver plays a key role in glucose metabolism and homeostasis, and impaired hepatic glucose metabolism contributes to the development of type 2 diabetes. However, the precise gene expression profile of diabetic liver and its association with diabetes and related diseases are yet to be further...

  • Lipid-Lowering Agents in Nonalcoholic Fatty Liver Disease and Steatohepatitis: Human Studies. Nseir, William; Mograbi, Julnar; Ghali, Murad // Digestive Diseases & Sciences;Jul2012, Vol. 57 Issue 7, p1773 

    Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease which refers to the presence of hepatic steatosis without significant intake of alcohol. NAFLD is an asymptomatic disease that can progress to nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular...

  • Diabetic silkworms for evaluation of therapeutically effective drugs against type II diabetes. Matsumoto, Yasuhiko; Ishii, Masaki; Hayashi, Yohei; Miyazaki, Shinya; Sugita, Takuya; Sumiya, Eriko; Sekimizu, Kazuhisa // Scientific Reports;5/29/2015, p10722 

    We previously reported that sugar levels in the silkworm hemolymph, i.e., blood, increase immediately (within 1 h) after intake of a high-glucose diet, and that the administration of human insulin decreases elevated hemolymph sugar levels in silkworms. In this hyperglycemic silkworm model,...

  • Hepatotoxicity with thiazolidinediones: is it a class effect? Scheen, A.J. // Drug Safety;Sep2001, Vol. 24 Issue 12, p873 

    Decreased insulin sensitivity plays a major role in various human diseases, particularly type 2 diabetes mellitus, and is associated with a higher risk of atherosclerosis and cardiovascular complications. Thiazolidinediones, more commonly termed glitazones, are the first drugs to specifically...

  • Raised liver enzymes in newly diagnosed type 2 diabetes. Joob, Beuy; Wiwanitkit, Viroj // Indian Journal of Endocrinology & Metabolism;May/Jun2013, Vol. 17 Issue 3, p535 

    A letter to the editor is presented in response to the article "Raised Liver Enzymes in Newly Diagnosed Type 2 Diabetes Are Associated With Weight and Lipids, But Not Glycaemic Control," by S. Saligram and colleagues in the 2012 issue.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics